Establishment of a Cell Culture Model of Persistent Flaviviral Infection: Usutu Virus Shows Sustained Replication during Passages and Resistance to Extinction by Antiviral Nucleosides.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
17 06 2019
Historique:
received: 22 03 2019
revised: 02 06 2019
accepted: 15 06 2019
entrez: 20 6 2019
pubmed: 20 6 2019
medline: 25 7 2020
Statut: epublish

Résumé

Chronic viral disease constitutes a major global health problem, with several hundred million people affected and an associated elevated number of deaths. An increasing number of disorders caused by human flaviviruses are related to their capacity to establish a persistent infection. Here we show that Usutu virus (USUV), an emerging zoonotic flavivirus linked to sporadic neurologic disease in humans, can establish a persistent infection in cell culture. Two independent lineages of Vero cells surviving USUV lytic infection were cultured over 82 days (41 cell transfers) without any apparent cytopathology crisis associated. We found elevated titers in the supernatant of these cells, with modest fluctuations during passages but no overall tendency towards increased or decreased infectivity. In addition to full-length genomes, viral RNA isolated from these cells at passage 40 revealed the presence of defective genomes, containing different deletions at the 5' end. These truncated transcripts were all predicted to encode shorter polyprotein products lacking membrane and envelope structural proteins, and most of non-structural protein 1. Treatment with different broad-range antiviral nucleosides revealed that USUV is sensitive to these compounds in the context of a persistent infection, in agreement with previous observations during lytic infections. The exposure of infected cells to prolonged treatment (10 days) with favipiravir and/or ribavirin resulted in the complete clearance of infectivity in the cellular supernatants (decrease of ~5 log

Identifiants

pubmed: 31212939
pii: v11060560
doi: 10.3390/v11060560
pmc: PMC6630443
pii:
doi:

Substances chimiques

Amides 0
Antiviral Agents 0
Pyrazines 0
RNA, Viral 0
Viral Proteins 0
Ribavirin 49717AWG6K
favipiravir EW5GL2X7E0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Vector Borne Zoonotic Dis. 2004 Summer;4(2):109-22
pubmed: 15228811
Lancet Infect Dis. 2016 Sep;16(9):1000-1001
pubmed: 27427201
PLoS One. 2012;7(10):e47912
pubmed: 23112871
J Biol Chem. 2011 Jun 24;286(25):22147-59
pubmed: 21511946
J Med Virol. 1993 Aug;40(4):326-9
pubmed: 8228925
Cell Stem Cell. 2016 Nov 3;19(5):663-671
pubmed: 27524440
J Virol. 2009 Nov;83(22):11765-76
pubmed: 19726510
Pathog Dis. 2014 Jul;71(2):137-63
pubmed: 24737600
mBio. 2016 May 24;7(3):
pubmed: 27222466
Future Virol. 2018 Jul;13(7):493-503
pubmed: 30245734
Antimicrob Agents Chemother. 2017 Oct 24;61(11):
pubmed: 28848019
J Neurovirol. 2015 Feb;21(1):92-7
pubmed: 25361698
Microbes Infect. 2015 Feb;17(2):163-8
pubmed: 25499188
Infect Immun. 1974 Dec;10(6):1362-9
pubmed: 4215763
J Virol. 1998 Mar;72(3):2474-82
pubmed: 9499109
Avian Pathol. 2005 Oct;34(5):392-5
pubmed: 16236570
Methods Mol Biol. 2019;1911:157-168
pubmed: 30593624
Cell. 2009 Jul 10;138(1):30-50
pubmed: 19596234
Euro Surveill. 2016 Nov 10;21(45):
pubmed: 27918257
N Engl J Med. 2016 Jun 2;374(22):2195-8
pubmed: 27074370
Lancet Gastroenterol Hepatol. 2017 Mar;2(3):161-176
pubmed: 28404132
Viruses. 2016 Sep 10;8(9):
pubmed: 27626437
Viruses. 2015 Jan 19;7(1):219-38
pubmed: 25606971
Virus Res. 2018 Aug 2;254:34-40
pubmed: 28899653
Euro Surveill. 2017 Apr 6;22(14):
pubmed: 28422005
J Virol. 2015 Apr;89(7):3455-70
pubmed: 25568208
Ticks Tick Borne Dis. 2017 Oct;8(6):895-906
pubmed: 28784308
J Virol. 2013 Jun;87(11):6172-81
pubmed: 23536652
Lancet. 2017 Jul 22;390(10092):357
pubmed: 28745597
Euro Surveill. 2009 Dec 17;14(50):
pubmed: 20070936
J Virol. 2015 Jan;89(1):626-42
pubmed: 25339775
Cell Host Microbe. 2017 Feb 8;21(2):134-142
pubmed: 28182948
Euro Surveill. 2017 Oct;22(41):
pubmed: 29043962
N Engl J Med. 2018 Nov 29;379(22):2173-2176
pubmed: 30485769
Curr Top Microbiol Immunol. 2016;392:323-39
pubmed: 26294225
J Virol. 2015 Sep;89(17):8880-96
pubmed: 26085147
Arch Virol. 2013 Mar;158(3):583-99
pubmed: 23129130
Front Microbiol. 2014 Jun 03;5:266
pubmed: 24917859
Antiviral Res. 2018 Dec;160:137-142
pubmed: 30385306
J Virol. 2006 Nov;80(22):11082-93
pubmed: 16956932
PLoS Negl Trop Dis. 2013 Oct 24;7(10):e2509
pubmed: 24205422
Emerg Infect Dis. 2002 Jul;8(7):652-6
pubmed: 12095429
Euro Surveill. 2018 Oct;23(43):
pubmed: 30376913
Antimicrob Agents Chemother. 2018 Aug 27;62(9):
pubmed: 29914957
PLoS Pathog. 2009 Nov;5(11):e1000658
pubmed: 19911056
J Clin Virol. 2011 Mar;50(3):221-3
pubmed: 21156352
Virology. 2012 May 25;427(1):10-7
pubmed: 22365325
J Virol. 2003 Jan;77(1):25-36
pubmed: 12477807
N Engl J Med. 2017 Feb 14;379(13):1234-1243
pubmed: 28195756
J Virol. 1981 Aug;39(2):413-21
pubmed: 6168773
Am J Trop Med Hyg. 2013 Mar;88(3):455-60
pubmed: 23358636
Elife. 2014 Oct 21;3:e03679
pubmed: 25333492
PLoS Med. 2016 Mar 01;13(3):e1001967
pubmed: 26930627
World J Hepatol. 2015 Nov 18;7(26):2676-80
pubmed: 26609344
Lancet. 2008 Feb 9;371(9611):500-9
pubmed: 18262042
Antiviral Res. 2018 Mar;151:97-104
pubmed: 29289666
World J Hepatol. 2015 Sep 8;7(19):2194-201
pubmed: 26380044
Methods Mol Biol. 2009;510:329-36
pubmed: 19009272
Euro Surveill. 2017 Jan 26;22(4):
pubmed: 28181903
Hum Vaccin Immunother. 2018 Feb 1;14(2):337-344
pubmed: 29053401
Am J Trop Med Hyg. 2017 Dec;97(6):1913-1919
pubmed: 29141749
BMC Infect Dis. 2011 May 17;11:131
pubmed: 21586142
Clin Exp Immunol. 2017 Jun;188(3):363-370
pubmed: 27753065
J Neurovirol. 2014 Dec;20(6):539-60
pubmed: 25287260
Emerg Infect Dis. 2018 May;24(5):875-878
pubmed: 29664365
Microbes Infect. 2017 Jul - Aug;19(7-8):380-381
pubmed: 28619684
J Med Entomol. 2012 Jan;49(1):132-42
pubmed: 22308781
Clin Microbiol Infect. 2017 Jan;23(1):33-37
pubmed: 27677699
J Exp Med. 2017 Aug 7;214(8):2303-2313
pubmed: 28694387
J Microbiol Immunol Infect. 2018 Aug;51(4):446-455
pubmed: 28698039
Virology. 2015 Aug;482:67-71
pubmed: 25827530
J Infect Dis. 2016 Feb 1;213 Suppl 1:S27-31
pubmed: 26744429
PLoS Negl Trop Dis. 2013 Jun 13;7(6):e2275
pubmed: 23785537
J Immunol. 2010 May 15;184(10):5914-27
pubmed: 20404278
Cell. 2016 Aug 25;166(5):1247-1256.e4
pubmed: 27565347
mBio. 2015 Jun 04;6(3):e00614
pubmed: 26045539
Microb Pathog. 2017 Feb;103:71-79
pubmed: 28012987

Auteurs

Raquel Navarro Sempere (RN)

Life Science & Bioengineering Building, Technical University of Denmark, 2800 Kongens Lyngby, Denmark. rnsempere@abiopep.com.
Abiopep Sociedad Limitada, Parque Científico de Murcia, 30100 Murcia, Spain. rnsempere@abiopep.com.

Armando Arias (A)

Life Science & Bioengineering Building, Technical University of Denmark, 2800 Kongens Lyngby, Denmark. aaesteban2@gmail.com.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing
1.00
Humans Yoga Low Back Pain Female Male
Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell

Classifications MeSH